AI Therapy vs Human Therapy: What's the Difference?
Reviewed byWendy Delgado, P.A.
SiggyMD Clinical Team · Last updated June 24, 2026
Key Takeaways
- AI therapy chatbots have shown measurable effectiveness in clinical research. A 2025 NEJM AI randomized controlled trial found that a generative AI chatbot (Therabot) produced significant reductions in depression and anxiety symptoms, with effect sizes of 0.79 to 0.90 compared to controls.
- Traditional human therapy remains more effective overall. Head-to-head data shows human therapy produces approximately 45 to 50 percent symptom reduction versus 30 to 35 percent for AI chatbots in anxiety. But nearly 50 percent of people who could benefit from therapy cannot access it.
- Unsupervised AI therapy carries documented risks. Stanford research found that widely used AI therapy chatbots showed stigmatizing responses and failed to safely handle suicidal ideation in direct testing.
- The meaningful distinction is not AI vs. human. It is supervised vs. unsupervised AI. A licensed clinician reviewing and approving everything the AI does changes the safety and reliability profile entirely.
- SiggyMD is not an AI therapist. It is an AI-assisted intake and monitoring system with licensed prescriber oversight on every clinical decision. The AI gathers information and tracks patterns. A licensed prescriber makes all treatment decisions.
The question most people are actually asking when they search “AI therapy vs human therapy” is: is this safe, and can it actually help me?
Those are reasonable questions. The answers depend on which kind of AI mental health tool you’re talking about.
There is a meaningful difference between an AI chatbot that acts as your therapist with no human oversight, and an AI-assisted system where a licensed clinician reviews everything the AI does before clinical decisions are made. That distinction matters more than the question of AI versus human.
What This Page Covers
- What AI therapy actually does in practice
- What human therapy provides that AI currently cannot
- What the clinical research shows on effectiveness
- Where AI therapy has documented risks
- The emerging hybrid model that most research supports
- How SiggyMD fits into this picture (and what it is not)
What AI Therapy Actually Does Today
The term “AI therapy” covers a wide range of tools, from simple symptom trackers to generative AI chatbots that conduct full therapy-like conversations.
Most AI therapy tools in current use deliver some combination of:
- Structured intake and assessment: gathering symptoms, history, and context using clinical frameworks
- Evidence-based content delivery: walking users through CBT techniques, coping strategies, psychoeducation, and mindfulness exercises
- Daily check-ins: brief mood, sleep, and symptom tracking between human-led appointments
- Crisis detection and escalation: flagging language or patterns that suggest acute risk
- 24/7 availability: reaching people at 2 a.m. when human support is not available
What AI tools cannot reliably do is what a licensed clinician does: make diagnostic assessments, prescribe medication, navigate complex clinical judgment calls, manage crisis situations, and provide the kind of human therapeutic alliance that decades of research associate with long-term treatment outcomes.
What Human Therapy Provides
Human-delivered therapy has a 50+ year evidence base across hundreds of thousands of patients. Cognitive behavioral therapy (CBT) for depression and anxiety, for instance, has been tested in more randomized controlled trials than almost any other psychological intervention.
What human therapy provides that AI currently cannot match:
Therapeutic alliance. Decades of psychotherapy research identify the therapeutic relationship as one of the strongest predictors of outcomes, accounting for as much variance as the specific technique used. Human therapists provide empathy, non-judgmental presence, and the experience of being understood by another person. This has not been replicated by AI systems.
Clinical judgment. Trained clinicians can recognize presentations that don’t fit standard patterns, identify when a patient’s self-report may not reflect their clinical state, manage diagnostic complexity, and navigate situations where the evidence base is unclear.
Safe crisis management. A licensed therapist encountering suicidal ideation in a session has protocols, legal obligations, and training that AI chatbots do not.
Diagnosis and prescribing authority. Only licensed clinicians can diagnose mental health conditions and prescribe medication. AI systems, regardless of sophistication, operate outside this domain.
What the Research Shows
AI therapy has demonstrated real clinical benefit
These findings are meaningful. AI-delivered support produces measurable, statistically significant clinical benefits for people with depression and anxiety.
Traditional therapy remains more effective overall
The clinical question isn’t whether AI therapy equals human therapy. It is whether 30 percent symptom reduction accessible immediately and at low cost is better than no treatment while waiting months for a human appointment.
The access problem is real
Research consistently shows that approximately 50 percent of individuals who could benefit from therapeutic services are unable to access them. Wait times for psychiatric appointments commonly run 3 to 6 months. In this context, AI tools serve a population that would otherwise receive nothing.
Where AI Therapy Falls Short and Becomes Risky
Not all AI mental health tools are equivalent, and the risks of unsupervised AI therapy are documented and serious.
These risks are not inherent to AI in mental health. They are specific to AI operating without clinical oversight and without accountability structures that govern licensed practitioners.
The Hybrid Model: What the Evidence Supports
The clinical research increasingly points toward a hybrid model as the most effective approach: AI for structured support, data collection, and accessibility; human clinicians for diagnosis, prescribing, and complex clinical judgment.
The key design feature that separates higher-risk from lower-risk AI mental health tools is clinical oversight: who reviews what the AI does, and what authority do they have to intervene?
The Distinction That Matters: Supervised vs. Unsupervised AI
The meaningful division in AI mental health care is not AI versus human. It is supervised versus unsupervised AI.
An AI chatbot that conducts therapy sessions without any human review operates without the clinical safeguards that govern licensed practitioners. It cannot be held to a standard of care. It has no license at risk if it handles a crisis poorly.
An AI system where every clinical decision is reviewed and approved by a licensed clinician operates within the existing medical accountability structure. The AI gathers information and supports monitoring. The human makes clinical decisions.
“The question I ask about any AI mental health tool is: what happens when something goes wrong? Who is responsible? Who has the license and training to manage a crisis or a complex presentation? If the answer is no one, that’s the risk,” says Wendy Delgado, P.A., of the SiggyMD clinical team. “When I review every intake and approve every treatment plan, I’m the accountable clinician. The AI helps me see more data and respond faster. It doesn’t replace my judgment.”
About SiggyMD
SiggyMD is not an AI therapist. It is an AI-assisted clinical intake and medication management system with licensed prescriber oversight on every clinical decision.
Here is how it works: A patient completes an anonymous AI-led clinical intake (no login, no name, no email required). A licensed prescriber reviews the complete intake, including structured assessment data, PHQ-9 results, and clinical history. The prescriber approves a treatment plan before anything is prescribed. After starting medication, daily AI check-ins track mood, sleep, side effects, and adherence, with that data visible to the prescriber.
The AI handles structure, scale, and continuity. The licensed clinician handles diagnosis, prescribing, and complex clinical judgment. No medication is prescribed or adjusted without human review.
SiggyMD’s clinical scope is anxiety and depression medication management. It is not a therapy replacement. For people who also want therapy, that is a separate clinical relationship.
For more on how AI mental health tools compare in practice, see our post on clinically supervised AI vs. unsupervised apps or our guide on the future of AI in mental healthcare.
Start your anonymous intake with SiggyMD to connect with a licensed prescriber who reviews your full clinical picture before anything is prescribed.
What Members Are Saying
TL
T.L., 31
Anxiety, Generalized
“I had tried three different therapy apps before SiggyMD. The AI conversations felt helpful in the moment but nothing changed. What was different here was that a real prescriber was reviewing everything and actually making clinical decisions. That’s not the same as talking to an AI.”
MS
M.S., 26
Depression
“I felt more comfortable talking to the AI intake than I would have answering the same questions with a stranger. I have social anxiety. The anonymous part helped me be honest. But knowing a licensed doctor was reading all of it and making the actual treatment decision made it feel safe. Not a chatbot pretending to be care.”
Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary.
The Bottom Line
AI therapy has real clinical benefits and a growing evidence base. Human therapy remains more effective overall and provides capabilities that AI cannot currently replicate. Neither is accessible to everyone who needs mental health support.
The most promising and best-supported model combines AI-driven structure and accessibility with human clinical judgment and oversight. The critical question when evaluating any AI mental health tool is not whether it uses AI. It is who reviews and is accountable for what the AI does.
Sources
-
Heinz MV, et al. Randomized trial of a generative AI chatbot for mental health treatment. NEJM AI. 2025;2:AIoa2400802.
-
Zhong W, Luo J, Zhang H. The therapeutic effectiveness of artificial intelligence-based chatbots in alleviation of depressive and anxiety symptoms in short-course treatments: A systematic review and meta-analysis. J Affect Disord. 2024;356:459-469.
-
Spytska L. The use of artificial intelligence in psychotherapy: development of intelligent therapeutic systems. BMC Psychology. 2025;13:175.
-
Stanford HAI. Exploring the Dangers of AI in Mental Health Care. Stanford University. 2024.
-
WHO. Mental disorders. World Health Organization. Updated 2022.
-
NIMH. Mental Health Medications. Updated 2024.
Frequently Asked Questions
Is AI therapy as effective as human therapy?
Not yet, by current evidence. A 2025 randomized controlled trial published in NEJM AI found a generative AI chatbot (Therabot) produced large effect sizes for depression and anxiety reduction over 8 weeks. But comparison studies indicate traditional human therapy typically achieves higher symptom reduction rates. The real-world advantage of AI is access, not superiority: millions of people who can't get to a human therapist can use AI tools. Whether that partial benefit is better than no access at all is a genuine clinical question.
What are the risks of AI therapy?
Unsupervised AI therapy carries documented clinical risks. Stanford research found that major AI therapy chatbots showed increased stigmatization of certain mental health conditions and failed to appropriately handle suicidal ideation, in one case providing information about tall bridges when a user described losing their job. There are also concerns about dependency, lack of appropriate escalation, and absence of crisis protocols. These risks are significantly reduced when AI operates within a clinically supervised model with human oversight.
Can AI replace a therapist?
No, and most clinical researchers don't argue it should. What AI can do is increase access, deliver structured evidence-based content consistently, and support ongoing monitoring between human-led appointments. What it cannot reliably do is provide the therapeutic alliance, contextual judgment, and crisis management that trained human clinicians provide. The emerging consensus in the field favors hybrid models: AI handles structured support and data collection, human clinicians handle diagnosis, prescribing, and complex clinical judgment.
What is the difference between AI therapy and AI-assisted care?
AI therapy (AI as the primary therapeutic agent) means a chatbot conducting therapy sessions without human review or oversight. AI-assisted care means a licensed clinician uses AI tools to gather structured information, monitor patient progress, and flag concerns, but makes all clinical decisions themselves. AI-assisted care is the model most research supports: the AI handles scale and continuity; the human handles clinical judgment.
Is SiggyMD an AI therapist?
No. SiggyMD is not a therapist and does not describe itself as one. The AI conducts an anonymous clinical intake, gathers structured information, and supports daily mood and medication tracking. A licensed prescriber reviews every intake and approves every treatment plan. No medication is prescribed without a human clinician reviewing and approving the plan. SiggyMD's clinical scope is anxiety and depression medication management, not therapy.
Mental healthcare should stay with you between appointments.
SiggyMD combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.